ENTER MEDITECH IVS: Financial statements 2019
CVR: 36507691
Source: annual report 2019, Danish Business Authority
01/02/2018 – 31/01/2019
ENTER MEDITECH IVS (CVR 36507691) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -12,439 the year before. Equity in the 2019 report amounted to DKK 130,804. The solvency ratio was 86.4%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 130,804
- Total Assets
- DKK 151,348
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 131 t. | - |
| 2018 | -12 t. | -12 t. | -12 t. | 131 t. | - |
| 2017 | -58 t. | -58 t. | -73 t. | 143 t. | - |
| 2016 | - | -187 t. | -196 t. | 216 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout ENTER MEDITECH IVS
ENTER MEDITECH IVS was a Danish company of the type Iværksætterselskab based in Dronninglund, founded in 2015. The company has been dissolved on 26 February 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -12,439 the year before. Equity in the 2019 report amounted to DKK 130,804.